New Zealand markets closed

Avenue Therapeutics, Inc. (ATXI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.7200-0.1500 (-5.23%)
At close: 04:00PM EDT
2.8000 +0.08 (+2.94%)
After hours: 06:09PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.48M
Enterprise value -709.80k
Trailing P/E 0.21
Forward P/E 17.99
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.88
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -0.20
52-week change 3-96.55%
S&P500 52-week change 318.96%
52-week high 382.5000
52-week low 32.6000
50-day moving average 33.5269
200-day moving average 311.6554

Share statistics

Avg vol (3-month) 378.85k
Avg vol (10-day) 3143.01k
Shares outstanding 5940.99k
Implied shares outstanding 6940.99k
Float 8871.52k
% held by insiders 11.90%
% held by institutions 11.99%
Shares short (15 Jul 2024) 440.81k
Short ratio (15 Jul 2024) 41.52
Short % of float (15 Jul 2024) 44.34%
Short % of shares outstanding (15 Jul 2024) 44.34%
Shares short (prior month 14 Jun 2024) 442.44k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:75
Last split date 326 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-125.66%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-7.18M
Diluted EPS (ttm)12.6700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.19M
Total cash per share (mrq)3.39
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.34
Book value per share (mrq)4.80

Cash flow statement

Operating cash flow (ttm)-11M
Levered free cash flow (ttm)-18.4M